![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Fresenius Will Buy Dialysis Firm for $3.5 Billion
Fresenius Will Buy Dialysis Firm for $3.5 Billion
May 6, 2005
Fresenius Medical Care said it will acquire U.S.-based Renal Care Group in a $3.5 billion deal that would make it one of the world's biggest dialysis care firms. Shares of Renal Care set a new high for the year in New York trading. Fresenius said it would pay $48 a share for the Nashville-based company. The deal is subject to regulatory approval in the U.S. and Europe.
Boston.com (http://www.boston.com/business/articles/2005/05/05/fresenius_will_buy_dialysis_firm_for_35b/)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct